{"gene":"CSNK1G2","run_date":"2026-06-09T22:57:19","timeline":{"discoveries":[{"year":2020,"finding":"CSNK1G2 binds to and inhibits the activation of RIPK3, thereby attenuating RIPK3-mediated necroptosis. This binding is triggered by auto-phosphorylation of CSNK1G2 at serine 211/threonine 215 sites in its C-terminal domain. CSNK1G2-knockout mice showed enhanced necroptosis and premature testis aging, rescued by Ripk3 double knockout or RIPK1 kinase inhibitor treatment, placing CSNK1G2 upstream of RIPK3 in the necroptosis pathway.","method":"Co-immunoprecipitation/binding assay, phosphosite mutagenesis, CSNK1G2-KO mouse model, genetic epistasis (double KO with Ripk3), pharmacological rescue with RIPK1 inhibitor","journal":"eLife","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal binding assays, phosphosite identification, KO mouse phenotype rescued by two independent genetic/pharmacological approaches across labs","pmids":["33206046"],"is_preprint":false},{"year":2021,"finding":"CSNK1G2 phosphorylates ERα at serine 167, regulating ERα transcriptional activity at estrogen-responsive elements (ERE) of estrogen-responsive genes (CTSD, GREB1). CSNK1G2 knockdown in ER+ breast cancer cells enhanced tamoxifen-mediated decrease in PI3K/AKT/mTOR/S6K signaling but not ERK signaling, while in ER- cells only ERK and PI3K signaling was altered. ERα silencing blocked CSNK1G2-induced tamoxifen sensitivity.","method":"shRNA knockdown, phosphorylation assay (Ser167 ERα), luciferase reporter for ERE, western blotting of PI3K/AKT/mTOR/S6K and ERK pathways, tumor sphere formation, CK1 inhibitor (D4476) treatment","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal methods (phosphorylation assay, reporter, pathway western blots, KD) from a single lab","pmids":["33861751"],"is_preprint":false},{"year":2023,"finding":"C. elegans CSNK-1 (ortholog of CSNK1G2) regulates oxidative stress response and ROS levels by interacting with the NADPH dual oxidase complex component DOXA-1; genetic nonallelic noncomplementation between csnk-1 and bli-3/tsp-15/doxa-1 NADPH dual oxidase genes was observed. Biochemical interaction was detected between DOXA-1 and CSNK-1, with evidence of a similar interaction between human orthologs DUOXA2 and CSNK1G2. CSNK1G2 and DUOXA2 each promoted ROS levels in human cells, effects suppressed by a CK1 inhibitor. Genetic interaction between csnk-1 and skn-1/Nrf2 was also detected.","method":"Genetic epistasis (nonallelic noncomplementation screen), co-immunoprecipitation/biochemical interaction assay, ROS level measurement in C. elegans, ROS assay in human cells with CK1 inhibitor, survival assay under oxidative stress","journal":"PLoS genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic epistasis plus biochemical interaction in worm and human cell validation, single lab, multiple orthogonal methods","pmids":["37099597"],"is_preprint":false},{"year":1997,"finding":"Human CSNK1G2 encodes a 416-amino-acid serine/threonine kinase with 94% identity to rat CKIγ2. The C-terminal region contains an SH3 domain-binding motif (Pro-Ser-Glu-Pro) conserved between rat and human, suggesting potential binding to signaling adaptor protein Nck (NCK). The gene was mapped to chromosome 19p13.3 by FISH and PCR analysis of human/rodent hybrid cell panels.","method":"cDNA cloning and sequencing, fluorescence in situ hybridization (FISH), PCR analysis of human/rodent hybrid cell panel","journal":"Genomics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct chromosomal mapping by FISH and hybrid cell panel; SH3-motif binding to Nck is structural inference, not experimentally confirmed binding","pmids":["9403068"],"is_preprint":false},{"year":2024,"finding":"CK1G2 (CSNK1G2) acts downstream of PKC eta in a kinase cascade that promotes terminal T cell exhaustion. PKC eta, but not PKC theta, promotes activity of CK1G2. Deletion of the gene encoding CK1G2 improved T cell function and tumor control in vivo, placing CK1G2 as a downstream effector of PKC eta in the terminal exhaustion program.","method":"Phosphoproteomics (downstream cascade mapping), genetic deletion (CK1G2 KO), in vivo tumor control assay, chronic infection model","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — phosphoproteomics cascade plus KO functional rescue, single preprint lab, multiple orthogonal methods","pmids":["bio_10.1101_2024.09.26.615103"],"is_preprint":true}],"current_model":"CSNK1G2 is a membrane-associated serine/threonine casein kinase 1 gamma family member that suppresses RIPK3-mediated necroptosis by directly binding and inhibiting RIPK3 (binding triggered by CSNK1G2 auto-phosphorylation at S211/T215), phosphorylates ERα at S167 to regulate estrogen-responsive transcription and PI3K/AKT/mTOR signaling in breast cancer cells, interacts with NADPH dual oxidase complex component DUOXA2 to regulate ROS homeostasis, and acts downstream of PKC eta to promote terminal CD8+ T cell exhaustion."},"narrative":{"mechanistic_narrative":"CSNK1G2 is a serine/threonine casein kinase 1 gamma-family enzyme that operates as a signaling node in cell death, hormone-responsive transcription, and redox homeostasis [PMID:33206046, PMID:33861751, PMID:9403068]. In the necroptosis pathway it acts upstream of RIPK3: auto-phosphorylation at S211/T215 in its C-terminal domain enables CSNK1G2 to bind and inhibit RIPK3 activation, and loss of CSNK1G2 in mice produces enhanced necroptosis and premature testis aging that is rescued by Ripk3 deletion or RIPK1 kinase inhibition [PMID:33206046]. In ER+ breast cancer cells CSNK1G2 phosphorylates ERα at S167 to drive transcription at estrogen-responsive elements and modulate PI3K/AKT/mTOR/S6K signaling, influencing tamoxifen sensitivity in an ERα-dependent manner [PMID:33861751]. Through interaction with the NADPH dual oxidase maturation factor DUOXA2 (DOXA-1 in C. elegans), CSNK1G2 promotes cellular ROS levels in a kinase-activity-dependent manner [PMID:37099597]. The protein is a 416-residue kinase encoded at chromosome 19p13.3 [PMID:9403068]. Beyond these roles, no unifying structural or substrate-level mechanism connecting these functions has been characterized in the available corpus.","teleology":[{"year":1997,"claim":"Established the basic molecular identity of human CSNK1G2 as a casein kinase 1 gamma serine/threonine kinase and placed it on the genome, providing the entry point for all later functional work.","evidence":"cDNA cloning/sequencing, FISH, and human/rodent hybrid cell panel mapping","pmids":["9403068"],"confidence":"Medium","gaps":["No enzymatic substrate identified at this stage","SH3-motif binding to Nck was structural inference, not demonstrated binding"]},{"year":2020,"claim":"Answered whether CSNK1G2 regulates programmed cell death by showing it directly binds and inhibits RIPK3, defining a kinase-dependent brake on necroptosis with an in vivo tissue phenotype.","evidence":"Co-IP/binding assays, phosphosite mutagenesis, CSNK1G2-KO mouse, epistasis with Ripk3 KO and RIPK1 inhibitor rescue","pmids":["33206046"],"confidence":"High","gaps":["Whether CSNK1G2 phosphorylates RIPK3 directly versus inhibiting by binding alone is not resolved","Structural basis of S211/T215 auto-phosphorylation-driven binding unknown"]},{"year":2021,"claim":"Connected CSNK1G2 to estrogen-responsive transcription by identifying ERα S167 as a phosphorylation target and linking the kinase to PI3K/AKT/mTOR signaling and tamoxifen response in breast cancer cells.","evidence":"shRNA knockdown, ERα S167 phosphorylation assay, ERE luciferase reporter, pathway western blots, CK1 inhibitor D4476","pmids":["33861751"],"confidence":"Medium","gaps":["Direct versus indirect phosphorylation of ERα not fully separated","Findings from a single lab and limited cell-line panel"]},{"year":2023,"claim":"Extended CSNK1G2 function to redox biology by showing a conserved interaction with the dual oxidase maturation factor DUOXA2/DOXA-1 that promotes ROS in a kinase-dependent manner.","evidence":"C. elegans nonallelic noncomplementation screen, Co-IP, ROS measurements in worm and human cells with CK1 inhibitor","pmids":["37099597"],"confidence":"Medium","gaps":["Whether DUOXA2 is a phosphorylation substrate is not established","Human relevance rests on cross-species inference and single-lab validation"]},{"year":2024,"claim":"Positioned CSNK1G2 as a downstream effector of a PKC eta cascade driving terminal CD8+ T cell exhaustion, with deletion improving T cell function and tumor control.","evidence":"Phosphoproteomic cascade mapping, CK1G2 KO, in vivo tumor and chronic infection models (preprint)","pmids":["bio_10.1101_2024.09.26.615103"],"confidence":"Medium","gaps":["Direct substrates of CSNK1G2 in the exhaustion program unidentified","Preprint, not peer-reviewed","Mechanism of PKC eta-driven activation undefined"]},{"year":null,"claim":"It remains unknown what unifies CSNK1G2's roles in necroptosis, ERα signaling, ROS, and T cell exhaustion at the level of shared substrates, regulatory inputs, or structural mechanism.","evidence":"","pmids":[],"confidence":"Low","gaps":["No structural model of the kinase or its substrate recognition","Substrate set across contexts not catalogued","Tissue-specific regulation of kinase activity uncharacterized"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[0,1,3]},{"term_id":"GO:0016740","term_label":"transferase activity","supporting_discovery_ids":[1,3]}],"localization":[],"pathway":[{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[0]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[1,4]}],"complexes":[],"partners":["RIPK3","DUOXA2"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P78368","full_name":"Casein kinase I isoform gamma-2","aliases":[],"length_aa":415,"mass_kda":47.5,"function":"Serine/threonine-protein kinase. Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. It can phosphorylate a large number of proteins. Participates in Wnt signaling (By similarity). Phosphorylates COL4A3BP/CERT, MTA1 and SMAD3. SMAD3 phosphorylation promotes its ligand-dependent ubiquitination and subsequent proteasome degradation, thus inhibiting SMAD3-mediated TGF-beta responses. Hyperphosphorylation of the serine-repeat motif of COL4A3BP/CERT leads to its inactivation by dissociation from the Golgi complex, thus down-regulating ER-to-Golgi transport of ceramide and sphingomyelin synthesis. Triggers PER1 proteasomal degradation probably through phosphorylation (PubMed:15077195, PubMed:15917222, PubMed:18794808, PubMed:19005213). Involved in brain development and vesicular trafficking and neurotransmitter releasing from small synaptic vesicles. Regulates fast synaptic transmission mediated by glutamate (By similarity). Involved in regulation of reactive oxygen species (ROS) levels (PubMed:37099597)","subcellular_location":"Cytoplasm, cell cortex; Cytoplasm","url":"https://www.uniprot.org/uniprotkb/P78368/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/CSNK1G2","classification":"Not Classified","n_dependent_lines":2,"n_total_lines":1208,"dependency_fraction":0.0016556291390728477},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/CSNK1G2","total_profiled":1310},"omim":[{"mim_id":"606274","title":"CASEIN KINASE I, GAMMA-1; CSNK1G1","url":"https://www.omim.org/entry/606274"},{"mim_id":"602214","title":"CASEIN KINASE I, GAMMA-2; CSNK1G2","url":"https://www.omim.org/entry/602214"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Vesicles","reliability":"Approved"},{"location":"Cytosol","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/CSNK1G2"},"hgnc":{"alias_symbol":["CK1g2"],"prev_symbol":[]},"alphafold":{"accession":"P78368","domains":[{"cath_id":"3.30.200.20","chopping":"42-121","consensus_level":"high","plddt":93.1455,"start":42,"end":121},{"cath_id":"1.10.510.10","chopping":"125-320","consensus_level":"high","plddt":97.2639,"start":125,"end":320}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P78368","model_url":"https://alphafold.ebi.ac.uk/files/AF-P78368-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P78368-F1-predicted_aligned_error_v6.png","plddt_mean":79.06},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=CSNK1G2","jax_strain_url":"https://www.jax.org/strain/search?query=CSNK1G2"},"sequence":{"accession":"P78368","fasta_url":"https://rest.uniprot.org/uniprotkb/P78368.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P78368/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P78368"}},"corpus_meta":[{"pmid":"30649385","id":"PMC_30649385","title":"The Genomic Landscape of Mucinous Breast Cancer.","date":"2019","source":"Journal of the National Cancer Institute","url":"https://pubmed.ncbi.nlm.nih.gov/30649385","citation_count":71,"is_preprint":false},{"pmid":"17660800","id":"PMC_17660800","title":"A molecular expression signature distinguishing follicular lesions in thyroid carcinoma using preamplification RT-PCR in archival samples.","date":"2007","source":"Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc","url":"https://pubmed.ncbi.nlm.nih.gov/17660800","citation_count":31,"is_preprint":false},{"pmid":"33206046","id":"PMC_33206046","title":"Casein kinase 1G2 suppresses necroptosis-promoted testis aging by inhibiting receptor-interacting kinase 3.","date":"2020","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/33206046","citation_count":28,"is_preprint":false},{"pmid":"33226164","id":"PMC_33226164","title":"Characterisation of sperm piRNAs and their correlation with semen quality traits in swine.","date":"2020","source":"Animal genetics","url":"https://pubmed.ncbi.nlm.nih.gov/33226164","citation_count":19,"is_preprint":false},{"pmid":"33745150","id":"PMC_33745150","title":"Genome-wide association study of stage III/IV grade C periodontitis (former aggressive periodontitis) in a Spanish population.","date":"2021","source":"Journal of clinical periodontology","url":"https://pubmed.ncbi.nlm.nih.gov/33745150","citation_count":18,"is_preprint":false},{"pmid":"33861751","id":"PMC_33861751","title":"CSNK1G2 differently sensitizes tamoxifen-induced decrease in PI3K/AKT/mTOR/S6K and ERK signaling according to the estrogen receptor existence in breast cancer cells.","date":"2021","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/33861751","citation_count":15,"is_preprint":false},{"pmid":"9403068","id":"PMC_9403068","title":"Cloning and chromosomal mapping of human casein kinase I gamma 2 (CSNK1G2).","date":"1997","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/9403068","citation_count":15,"is_preprint":false},{"pmid":"15342122","id":"PMC_15342122","title":"Polymorphisms of casein kinase I gamma 2 gene associated with simple febrile seizures in Chinese Han population.","date":"2004","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/15342122","citation_count":10,"is_preprint":false},{"pmid":"35602164","id":"PMC_35602164","title":"Plasma Proteins as Occupational Hazard Risk Monitors for Populations Working in Harsh Environments: A Mendelian Randomization Study.","date":"2022","source":"Frontiers in public health","url":"https://pubmed.ncbi.nlm.nih.gov/35602164","citation_count":7,"is_preprint":false},{"pmid":"37099597","id":"PMC_37099597","title":"Casein kinase 1 gamma regulates oxidative stress response via interacting with the NADPH dual oxidase complex.","date":"2023","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/37099597","citation_count":6,"is_preprint":false},{"pmid":"37781070","id":"PMC_37781070","title":"CSNK1G2-AS1 promotes metastasis, colony formation and serves as a biomarker in testicular germ cell tumor cells.","date":"2023","source":"Journal of Cancer","url":"https://pubmed.ncbi.nlm.nih.gov/37781070","citation_count":4,"is_preprint":false},{"pmid":"15300631","id":"PMC_15300631","title":"[Five single nucleotide polymorphisms of casein kinase I gamma 2 gene in children with familial febrile convulsions].","date":"2004","source":"Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/15300631","citation_count":1,"is_preprint":false},{"pmid":"40388790","id":"PMC_40388790","title":"Identification of therapeutic targets for neonatal respiratory distress: A systematic druggable genome-wide Mendelian randomization.","date":"2025","source":"Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/40388790","citation_count":0,"is_preprint":false},{"pmid":"41362988","id":"PMC_41362988","title":"[Replicative study of the involvement of long non-coding RNA genes in the manifestation of antisocial behavior].","date":"2025","source":"Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova","url":"https://pubmed.ncbi.nlm.nih.gov/41362988","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2024.09.26.615103","title":"Different signaling interpretations by PKC eta and theta control T cell function and exhaustion","date":"2024-09-27","source":"bioRxiv","url":"https://doi.org/10.1101/2024.09.26.615103","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":9847,"output_tokens":1720,"usd":0.027671,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":8543,"output_tokens":2168,"usd":0.048458,"stage2_stop_reason":"end_turn"},"total_usd":0.076129,"stage1_batch_id":"msgbatch_01ACAxJQabDsht39JXeWG22d","stage2_batch_id":"msgbatch_01QEU22A9U5sbPTgsMzTmvSf","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2020,\n      \"finding\": \"CSNK1G2 binds to and inhibits the activation of RIPK3, thereby attenuating RIPK3-mediated necroptosis. This binding is triggered by auto-phosphorylation of CSNK1G2 at serine 211/threonine 215 sites in its C-terminal domain. CSNK1G2-knockout mice showed enhanced necroptosis and premature testis aging, rescued by Ripk3 double knockout or RIPK1 kinase inhibitor treatment, placing CSNK1G2 upstream of RIPK3 in the necroptosis pathway.\",\n      \"method\": \"Co-immunoprecipitation/binding assay, phosphosite mutagenesis, CSNK1G2-KO mouse model, genetic epistasis (double KO with Ripk3), pharmacological rescue with RIPK1 inhibitor\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal binding assays, phosphosite identification, KO mouse phenotype rescued by two independent genetic/pharmacological approaches across labs\",\n      \"pmids\": [\"33206046\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"CSNK1G2 phosphorylates ERα at serine 167, regulating ERα transcriptional activity at estrogen-responsive elements (ERE) of estrogen-responsive genes (CTSD, GREB1). CSNK1G2 knockdown in ER+ breast cancer cells enhanced tamoxifen-mediated decrease in PI3K/AKT/mTOR/S6K signaling but not ERK signaling, while in ER- cells only ERK and PI3K signaling was altered. ERα silencing blocked CSNK1G2-induced tamoxifen sensitivity.\",\n      \"method\": \"shRNA knockdown, phosphorylation assay (Ser167 ERα), luciferase reporter for ERE, western blotting of PI3K/AKT/mTOR/S6K and ERK pathways, tumor sphere formation, CK1 inhibitor (D4476) treatment\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal methods (phosphorylation assay, reporter, pathway western blots, KD) from a single lab\",\n      \"pmids\": [\"33861751\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"C. elegans CSNK-1 (ortholog of CSNK1G2) regulates oxidative stress response and ROS levels by interacting with the NADPH dual oxidase complex component DOXA-1; genetic nonallelic noncomplementation between csnk-1 and bli-3/tsp-15/doxa-1 NADPH dual oxidase genes was observed. Biochemical interaction was detected between DOXA-1 and CSNK-1, with evidence of a similar interaction between human orthologs DUOXA2 and CSNK1G2. CSNK1G2 and DUOXA2 each promoted ROS levels in human cells, effects suppressed by a CK1 inhibitor. Genetic interaction between csnk-1 and skn-1/Nrf2 was also detected.\",\n      \"method\": \"Genetic epistasis (nonallelic noncomplementation screen), co-immunoprecipitation/biochemical interaction assay, ROS level measurement in C. elegans, ROS assay in human cells with CK1 inhibitor, survival assay under oxidative stress\",\n      \"journal\": \"PLoS genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic epistasis plus biochemical interaction in worm and human cell validation, single lab, multiple orthogonal methods\",\n      \"pmids\": [\"37099597\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"Human CSNK1G2 encodes a 416-amino-acid serine/threonine kinase with 94% identity to rat CKIγ2. The C-terminal region contains an SH3 domain-binding motif (Pro-Ser-Glu-Pro) conserved between rat and human, suggesting potential binding to signaling adaptor protein Nck (NCK). The gene was mapped to chromosome 19p13.3 by FISH and PCR analysis of human/rodent hybrid cell panels.\",\n      \"method\": \"cDNA cloning and sequencing, fluorescence in situ hybridization (FISH), PCR analysis of human/rodent hybrid cell panel\",\n      \"journal\": \"Genomics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct chromosomal mapping by FISH and hybrid cell panel; SH3-motif binding to Nck is structural inference, not experimentally confirmed binding\",\n      \"pmids\": [\"9403068\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"CK1G2 (CSNK1G2) acts downstream of PKC eta in a kinase cascade that promotes terminal T cell exhaustion. PKC eta, but not PKC theta, promotes activity of CK1G2. Deletion of the gene encoding CK1G2 improved T cell function and tumor control in vivo, placing CK1G2 as a downstream effector of PKC eta in the terminal exhaustion program.\",\n      \"method\": \"Phosphoproteomics (downstream cascade mapping), genetic deletion (CK1G2 KO), in vivo tumor control assay, chronic infection model\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — phosphoproteomics cascade plus KO functional rescue, single preprint lab, multiple orthogonal methods\",\n      \"pmids\": [\"bio_10.1101_2024.09.26.615103\"],\n      \"is_preprint\": true\n    }\n  ],\n  \"current_model\": \"CSNK1G2 is a membrane-associated serine/threonine casein kinase 1 gamma family member that suppresses RIPK3-mediated necroptosis by directly binding and inhibiting RIPK3 (binding triggered by CSNK1G2 auto-phosphorylation at S211/T215), phosphorylates ERα at S167 to regulate estrogen-responsive transcription and PI3K/AKT/mTOR signaling in breast cancer cells, interacts with NADPH dual oxidase complex component DUOXA2 to regulate ROS homeostasis, and acts downstream of PKC eta to promote terminal CD8+ T cell exhaustion.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"CSNK1G2 is a serine/threonine casein kinase 1 gamma-family enzyme that operates as a signaling node in cell death, hormone-responsive transcription, and redox homeostasis [#0, #1, #3]. In the necroptosis pathway it acts upstream of RIPK3: auto-phosphorylation at S211/T215 in its C-terminal domain enables CSNK1G2 to bind and inhibit RIPK3 activation, and loss of CSNK1G2 in mice produces enhanced necroptosis and premature testis aging that is rescued by Ripk3 deletion or RIPK1 kinase inhibition [#0]. In ER+ breast cancer cells CSNK1G2 phosphorylates ERα at S167 to drive transcription at estrogen-responsive elements and modulate PI3K/AKT/mTOR/S6K signaling, influencing tamoxifen sensitivity in an ERα-dependent manner [#1]. Through interaction with the NADPH dual oxidase maturation factor DUOXA2 (DOXA-1 in C. elegans), CSNK1G2 promotes cellular ROS levels in a kinase-activity-dependent manner [#2]. The protein is a 416-residue kinase encoded at chromosome 19p13.3 [#3]. Beyond these roles, no unifying structural or substrate-level mechanism connecting these functions has been characterized in the available corpus.\",\n  \"teleology\": [\n    {\n      \"year\": 1997,\n      \"claim\": \"Established the basic molecular identity of human CSNK1G2 as a casein kinase 1 gamma serine/threonine kinase and placed it on the genome, providing the entry point for all later functional work.\",\n      \"evidence\": \"cDNA cloning/sequencing, FISH, and human/rodent hybrid cell panel mapping\",\n      \"pmids\": [\"9403068\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No enzymatic substrate identified at this stage\", \"SH3-motif binding to Nck was structural inference, not demonstrated binding\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Answered whether CSNK1G2 regulates programmed cell death by showing it directly binds and inhibits RIPK3, defining a kinase-dependent brake on necroptosis with an in vivo tissue phenotype.\",\n      \"evidence\": \"Co-IP/binding assays, phosphosite mutagenesis, CSNK1G2-KO mouse, epistasis with Ripk3 KO and RIPK1 inhibitor rescue\",\n      \"pmids\": [\"33206046\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether CSNK1G2 phosphorylates RIPK3 directly versus inhibiting by binding alone is not resolved\", \"Structural basis of S211/T215 auto-phosphorylation-driven binding unknown\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Connected CSNK1G2 to estrogen-responsive transcription by identifying ERα S167 as a phosphorylation target and linking the kinase to PI3K/AKT/mTOR signaling and tamoxifen response in breast cancer cells.\",\n      \"evidence\": \"shRNA knockdown, ERα S167 phosphorylation assay, ERE luciferase reporter, pathway western blots, CK1 inhibitor D4476\",\n      \"pmids\": [\"33861751\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct versus indirect phosphorylation of ERα not fully separated\", \"Findings from a single lab and limited cell-line panel\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Extended CSNK1G2 function to redox biology by showing a conserved interaction with the dual oxidase maturation factor DUOXA2/DOXA-1 that promotes ROS in a kinase-dependent manner.\",\n      \"evidence\": \"C. elegans nonallelic noncomplementation screen, Co-IP, ROS measurements in worm and human cells with CK1 inhibitor\",\n      \"pmids\": [\"37099597\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether DUOXA2 is a phosphorylation substrate is not established\", \"Human relevance rests on cross-species inference and single-lab validation\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Positioned CSNK1G2 as a downstream effector of a PKC eta cascade driving terminal CD8+ T cell exhaustion, with deletion improving T cell function and tumor control.\",\n      \"evidence\": \"Phosphoproteomic cascade mapping, CK1G2 KO, in vivo tumor and chronic infection models (preprint)\",\n      \"pmids\": [\"bio_10.1101_2024.09.26.615103\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct substrates of CSNK1G2 in the exhaustion program unidentified\", \"Preprint, not peer-reviewed\", \"Mechanism of PKC eta-driven activation undefined\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"It remains unknown what unifies CSNK1G2's roles in necroptosis, ERα signaling, ROS, and T cell exhaustion at the level of shared substrates, regulatory inputs, or structural mechanism.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No structural model of the kinase or its substrate recognition\", \"Substrate set across contexts not catalogued\", \"Tissue-specific regulation of kinase activity uncharacterized\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [0, 1, 3]},\n      {\"term_id\": \"GO:0016740\", \"supporting_discovery_ids\": [1, 3]}\n    ],\n    \"localization\": [],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [0]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [1, 4]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"RIPK3\", \"DUOXA2\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":5,"faith_total":5,"faith_pct":100.0}}